Barclays’s iRadimed IRMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $1.71M | Sell |
|
|||||
|
2025
Q2 | $1.63M | Buy |
|
|||||
|
2025
Q1 | $1.09M | Sell |
|
|||||
|
2024
Q4 | $1.38M | Buy |
|
|||||
|
2024
Q3 | $1.2M | Buy |
|
|||||
|
2024
Q2 | $488K | Sell |
|
|||||
|
2024
Q1 | $649K | Sell |
|
|||||
|
2023
Q4 | $926K | Buy |
|
|||||
|
2023
Q3 | $472K | Buy |
|
|||||
|
2023
Q2 | $356K | Sell |
|
|||||
|
2023
Q1 | $374K | Buy |
|
|||||
|
2022
Q4 | $216K | Buy |
|
|||||
|
2022
Q3 | $152K | Sell |
|
|||||
|
2022
Q2 | $173K | Sell |
|
|||||
|
2022
Q1 | $825K | Buy |
|
|||||
|
2021
Q4 | $650K | Buy |
|
|||||
|
2021
Q3 | $301K | Buy |
|
|||||
|
2021
Q2 | $212K | Sell |
|
|||||
|
2021
Q1 | $290K | Buy |
|
|||||
|
2020
Q4 | $220K | Sell |
|
|||||
|
2020
Q3 | $216K | Sell |
|
|||||
|
2020
Q2 | $299K | Buy |
|
|||||
|
2020
Q1 | $93K | Sell |
|
|||||
|
2019
Q4 | $171K | Buy |
|
|||||
|
2019
Q3 | $113K | Buy |
|
|||||
|
2019
Q2 | $58K | Sell |
|
|||||
|
2019
Q1 | $82K | Buy |
|
|||||
|
2018
Q4 | $50K | Buy |
|
|||||
|
2018
Q3 | $50K | Buy |
|
|||||
|
2018
Q2 | $24K | Buy |
|
|||||
|
2018
Q1 | $0 | Buy |
|
|||||
|
2017
Q2 | – | Sell |
|
|||||
|
2017
Q1 | $12K | Buy |
|
|||||
|
2016
Q4 | $2K | Buy |
|
|||||
|
2016
Q3 | $1K | Buy |
|
|||||
|
2016
Q1 | – | Sell |
|
|||||
|
2015
Q4 | $537K | Buy |
|
|||||
|
2015
Q3 | $127K | Buy |
|
|||||
|
2015
Q2 | $1K | Buy |
|